Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam dose-finding and safety study for painless colonoscopy
ChiCTR2100052615Phase 4Completed
- Sponsor
- Hangzhou First People's Hospital
- Start
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of remimazolam and propofol in Colorectal disease (3 arms), sponsored by Hangzhou First People's Hospital. Primary endpoints: Modified Observer's Assessment of Alertness/Sedation score, Body movement response and 2 more. Started Nov 2021; status: completed.
02
Drugs
remimazolampropofol
03
Conditions
Colorectal disease
Beyond the preview
Go deeper on ChiCTR2100052615.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100052615.